Top Industry Leaders in the Biomarker Market
Latest Biomarker Companies Update
- Aug 2023: The annual sales and profit predictions for Edwards Lifesciences Corp were marginally increased, but slower-than-expected growth in revenue in the manufacturer of artificial heart valves caused its shares to decline 6% after the bell. However, heart surgeries have not returned as quickly as other procedures, affecting medical equipment producers counting on a robust rebound. Staffing shortages at American hospitals have improved, which has increased non-urgent treatments delayed by the epidemic. This is partially because some surgeries take longer to complete—four to six months from the initial diagnosis. The business stated that lower-than-expected growth in the market and competition trialing in the initial half of this year were still putting pressure on sales in Japan.
- June 2023: Illumina Ventures, a renowned venture capital firm focused on genomics and precision medicine, announced intentions to establish Illumina® Ventures Labs. Illumina Ventures Labs will run and provide access to fully functional genomics labs in the US plus the UK, mentorship, and seed finance to attract a wide range of genomics-related start-ups, building based on the Illumina Accelerator program. Instead of running its Accelerator program, Illumina, Inc. will give the start-ups technical advice from its subject matter experts and give Illumina Ventures Labs access to the company's next-generation sequencing (NGS) platforms. They are extending their partnership with Illumina as part of Illumina Ventures' ongoing effort to pursue earlier stages of investing. The program will expedite early-stage companies' timetables to their subsequent value inflection point and boost them while giving our fund more investment options.
-
Opko Health (US)
-
Quest Diagnostics Incorporated (US)
-
Eurofins Scientific (Luxembourg)
-
Sema4 (US)
-
Fulgenmt Genetics Inc. (US)
-
Invitae Corporation (US)
-
Laboratory Corporation of America Holdings (US)
-
Illumina Inc. (US)
